Molecular Diagnostics and Digital Health startup. We are providing breast cancer patients with faster and more precise risk stratification as we can predict a relapse from sera earlier than clinically available methods. Utilizing our computational modelling, we can assess the risk profile, molecular signatures and therapeutical targets so as to model pharmacodynamics of therapeutical agents. We're FUTURETICS, on a mission to develop a truly personalised prognostic and predictive DX tool for everyone.